BiotechTube
Home/Imvaria/Joshua Reicher, MD
JR

Joshua Reicher, MD

Co-founder & CEO

Imvaria

Therapeutic Areas

PulmonologyOncology

Imvaria Pipeline

DrugIndicationPhase
FibresolveIdiopathic Pulmonary Fibrosis (IPF) / Interstitial Lung Disease (ILD)Approved
ILD Prognostic BiomarkerInterstitial Lung Disease (ILD) Mortality PredictionDevelopment
Oncology Digital BiomarkersLung CancerDevelopment

Leadership Team at Imvaria

MM
Michael Muelly, MD
Co-founder & CTO
View full Imvaria profile